Fig. 1 · Structure

Documents & Downloads

5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid

Orforglipron Intermediate

5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid serves as an important intermediate in the synthesis of Orforglipron. This compound exhibits potential biological activity targeting metabolic pathways, making it valuable for research in diabetes and metabolic disorders. Its applicability extends to studies focusing on drug development and the exploration of pharmacological effects related to glucose regulation.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 2212021-83-3
Applications Orforglipron Intermediate
Formula C22H25N3O5
Molecular Weight 411.46
SMILES
O=C(O)C(N1[C@]2(C(N3)=NOC3=O)[C@@H](C)C2)=CC4=C1C=CC([C@H]5CCOC(C)(C)C5)=C4

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...